Cynvenio is the pioneer in LiquidBiopsy® technology for the genomic analysis of tumor cells from whole blood in support of cancer precision medicine strategies.

 
  ClearID ®  Clinical Testing   Complementary tests that support clinical decisions when monitoring patients before, during and after cancer treatment.   Visit ClearIDMonitoring.com →

ClearID® Clinical Testing

Complementary tests that support clinical decisions when monitoring patients before, during and after cancer treatment.

Visit ClearIDMonitoring.com →

  LiquidBiopsy ®  Platform   An automated rare cell isolation and staining front-end for all types of molecular characterization, especially sequencing.   Learn More →

LiquidBiopsy® Platform

An automated rare cell isolation and staining front-end for all types of molecular characterization, especially sequencing.

Learn More →

  LiquidBiopsy ®  Testing   A risk-free, painless method to dynamically sample study participants and sequentially measure response to treatment.   Learn More →

LiquidBiopsy® Testing

A risk-free, painless method to dynamically sample study participants and sequentially measure response to treatment.

Learn More →